
elevida is designed to offer therapeutic techniques and exercises based on evidence-based psychological-psychotherapeutic treatment methods, suitable for patients with Multiple Sclerosis (MS) and co-occurring fatigue, to support them in managing their fatigue. It is for independent use as an adjunct to usual care for patients aged 18+. It is not intended to replace provider treatments or provide diagnostic/therapeutic decision info. Indications: Multiple sclerosis [encephalomyelitis disseminata] (G35).
Pricing
Paid
Manufacturer price €243.00 per prescription (90 days). DiGA directory: https://diga.bfarm.de/en/verzeichnis/00419
Category
Digital Therapeutics
Tags
—
Added
Sep 2026
Conditions (ICD-10)
Categories
Pros
- Permanently listed in the German BfArM DiGA directory
- Prescribable and reimbursed by German statutory health insurance
- Therapeutic area: Nervous System